Protein kinase C and its isoforms in human breast cancer cells: Relationship to the invasive phenotype

International Journal of Oncology

Volumn 12, Issue 6, 1998, Pages 1349-1354

  Morse Gaudio, Michèle ^a   Connolly, Jeanne M ^a   Rose, David P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Breast cancer; E cadherin; Isoforms; Protein kinase C; Urokinase type plasminogen activator; Vimentin

Indexed keywords

ALPHA CATENIN; ESTROGEN RECEPTOR; PROTEIN KINASE C; UROKINASE; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031812220     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.6.1349     Document Type: Article

References (38)

1. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308: 693-698, 1984.
2. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
3. O'Brian CA, Vogel VG, Singletary SE and Ward NE: Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 49: 3215-3217, 1989.
4. Gordge PC, Hulme MJ, Clegg RA and Miller WR: Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 32A: 2120-2126, 1996.
5. 2+-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors, Int J Cancer 40: 344-348, 1987.
6. Fabbro D, Küng W, Roos W, Reguzzi R and Eppenberger U: Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res 46: 2720-2725, 1986.
7. Lee SA, Karaszkiewicz JW and Anderson WB: Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res 52: 3750-3759, 1992.
8. Ways DK, Kukoly CA, De Vente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP and Parker PJ: MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95: 1906-1915, 1995.
9. Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, Dabbs D and Demers L: Induction of a less aggressive breast cancer phenotype by protein kinase C-α and -β overexpression. Cell Growth Differ 7: 1187-1198, 1996.
10. Knudsen KA, Soler AP, Johnson KR and Wheelock MJ: Interaction of α-actinin with the cadherin/catenin cell-cell adhesion complex via α-catenin. J Cell Biol 130: 67-77, 1995.
11. Thompson EW, Paik S, Brünner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR and Dickson RB: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534-544, 1992.
12. Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM and Osborne CK: Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER-2/neu. Breast Cancer Res Treat 24: 85-95, 1993.
13. Kraus MH, Popescu NC, Amsbaugh SC and King CR: Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605-610, 1987.
14. Liu X-H and Rose DP: Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 56: 5125-5127, 1996.
15. Megidish T and Mazurek N: A mutant protein kinase C that can transform fibroblasts. Nature 342: 807-811, 1989.
16. Persons DA, Wilkison WO, Bell RM and Finn OJ: Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA. Cell 52: 447-458, 1988.
17. Gusovsky F and Gutkind JS: Selective effects of protein kinase C isozymes on cyclic AMP accumulation. Mol Pharmacol 39: 124-129, 1991.
18. Housey GM, Johnson MD, Hsiao WL, O'Brian CA, Murphy JP, Kirschmeier P and Weinstein IB: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343-354, 1988.
19. Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nicklin P, Meister L, Ziel R, Geiger T, Muller M and Fabbro D: Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res 56: 3499-3507, 1996.
20. Mischak H, Goodnight J, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH and Mushinski JF: Overexpression of protein kinase C-δ and -ε in NIH3T3 cells induces opposite effects on growth, morphology, anchorage dependence and tumorigenicity. J Biol Chem 268: 6090-6096, 1993.
21. Palmantier R, Roberts JD, Glasgow WC, Eling TE and Olden K: Regulation of the adhesion of a human breast carcinoma cell line to type IV collagen and vitronectin: roles for lipoxygenase and protein kinase C. Cancer Res 56: 2206-2212, 1996.
22. Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D and Huryk R: Overexpression of protein kinase C-zeta (PKC-ζ) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Cancer Res 56: 4137-4141, 1996.
23. Bae S-N, Arand G, Azzam H, Pavasant R, Torri J, Frandsen TL and Thompson EW: Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 24: 241-255, 1993.
24. Jones JL, Royall JE and Walker RA: E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer 74: 1237-1241, 1996.
25. Guriec N, Marcellin L, Gairard B, Caldéroli H, Wilk A, Renaud R, Bergerat J-P and Oberling F: E-cadherin mRNA expression in breast carcinomas correlates with overall survival and disease-free survival. Invasion Metastasis 16: 19-26, 1996.
26. Domagala W, Markiewski M, Harezga B, Dukowicz A and Osborn M: Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin Cancer Res 2: 147-154, 1996.
27. Seshadri R, Raymond WA, Leong AS-Y, Horsfall DJ and McCaul K: Vimentin expression is not associated with poor prognosis in breast cancer. Int J Cancer 67: 353-356, 1996.
28. Vleminckx K, Vakaet L Jr, Marcel M, Fiers W and van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119, 1991.
29. D'Souza B and Taylor-Papadimitriou J: Overexpression of erbB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci USA 91: 7202-7206, 1994.
30. Pierceall WE, Woodard AS, Morrow JS, Rimm D and Fearon ER: Frequent alterations in E-cadherin and α- and -β catenin expression in human breast cancer cell lines. Oncogene 11: 1319-1326, 1995.
31. Stover DM, Carey I, Garzon RJ and Zehner ZE: A negative regulatory factor is missing in a human metastatic breast cancer cell line. Cancer Res 54: 3092-3095, 1994.
32. Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP and Byers SW: Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Differ 2: 365-372, 1991.
33. Dumont JA, Jones WD Jr and Bitonti AJ: Inhibition of experimental metastasis and cell adhesion of B 16F1 melanoma cells by inhibitors of protein kinase C. Cancer Res 52: 1195-1200, 1992.
34. Liu B, Renaud C, Nelson KK, Chen YQ, Bazaz R, Kowynia J, Timar J, Diglio CA and Honn KV: Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int J Cancer 52: 147-152, 1992.
35. Schwartz GK, Redwood M, Ohnuma T, Holland JF, Droller MJ and Liu BC-S: Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. J Natl Cancer Inst 82: 1753-1756, 1990.
36. Mapelli E, Banfi P, Sala E, Sensi M, Supino R, Zunino F and Gambetta RA: Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes. Int J Cancer 57: 281-286, 1994.
37. Kwaan HC: The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11: 291-311, 1992.
38. Long BJ and Rose DP: Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells and a transfectant (S30) stably expressing ER. Cancer Lett 99: 209-215, 1996.